DC-S238

Overview

DC-S238 is an orally active and highly selective histone methyltransferase SET7 ( SETD7 ) inhibitor ( IC 50 =4.88 μM). DC-S238 is promising for research of cancer , diabetes and inflammatory diseases.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Signaling Pathways > Histone Methyltransferase

Product Information

• Catalog No.: HY-119164
• CAS No.: 832109-48-5
• Molecular Formula: C14H13N3O5S
• Molecular Weight: 335.34
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source